Ruhan A
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ruhan A has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Xiao-Ping Dong
National Key-Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, NHC Key Laboratory of Medical Virology and Viral Diseases, Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Beijing, China
5 shared publications - Cao Chen
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory for Medical Virology and Viral Diseases, Beijing Key Laboratory of Viral Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention & Chinese Academy of Preventive Medicine, Beijing 102206, China
4 shared publications - Liping Gao
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory for Medical Virology and Viral Diseases, Beijing Key Laboratory of Viral Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention & Chinese Academy of Preventive Medicine, Beijing 102206, China
4 shared publications - Bing Xu
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Chinese Academy of Preventive Medicine, Beijing 102206, China
3 shared publications - Ju-Zheng Li
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Chinese Academy of Preventive Medicine, Beijing 102206, China
3 shared publications - Qi Shi
National Key-Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, NHC Key Laboratory of Medical Virology and Viral Diseases, Chinese Center for Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, Beijing, China
3 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (11)
Genome‐wide association and multi‐omics analysis of sporadic Creutzfeldt–Jakob disease in a Chinese population
INTRODUCTION: Genetic susceptibility of sporadic Creutzfeldt–Jakob disease (sCJD) remains largely unexplored in East Asian populations. METHODS: We conducted the first case–control genome‐wide association study of sCJD susceptibility in a Chinese population, including 143 cases and 301 Chinese‐ancestry controls, followed by integrative multi‐omics gene prioritization using quantitative trait loci datasets. RESULTS: Eight loci showed suggestive association signals. Multi‐omics analyses prioritized candidate genes involved in lipid metabolism, endoplasmic reticulum (ER) proteostasis, cytoskeletal regulation, and membrane transport. Consistently prioritized candidate genes included slingshot protein phosphatase 1 , phospholipase A and acyltransferase 3 , DnaJ heat shock protein family (Hsp40) member C10 , CDP‐diacylglycerol synthase 1 , AT‐rich interaction domain 5B , membrane palmitoylated protein 7 , chromosome 18 open reading frame 25 , and telomerase associated protein 1 . Several loci showed population‐specific allele‐frequency patterns compared with European cohorts. DISCUSSION: These findings expand the genetic architecture of sCJD in non‐European populations and support lipid metabolism and ER protein quality control as candidate pathways in prion disease susceptibility.
- 16 November 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (11)
Open AccessGenome‐wide association and multi‐omics analysis of sporadic Creutzfeldt–Jakob disease in a Chinese population
INTRODUCTION: Genetic susceptibility of sporadic Creutzfeldt–Jakob disease (sCJD) remains largely unexplored in East Asian populations. METHODS: We conducted the first case–control genome‐wide association study of sCJD susceptibility in a Chinese population, including 143 cases and 301 Chinese‐ancestry controls, followed by integrative multi‐omics gene prioritization using quantitative trait loci datasets. RESULTS: Eight loci showed suggestive association signals. Multi‐omics analyses prioritized candidate genes involved in lipid metabolism, endoplasmic reticulum (ER) proteostasis, cytoskeletal regulation, and membrane transport. Consistently prioritized candidate genes included slingshot protein phosphatase 1 , phospholipase A and acyltransferase 3 , DnaJ heat shock protein family (Hsp40) member C10 , CDP‐diacylglycerol synthase 1 , AT‐rich interaction domain 5B , membrane palmitoylated protein 7 , chromosome 18 open reading frame 25 , and telomerase associated protein 1 . Several loci showed population‐specific allele‐frequency patterns compared with European cohorts. DISCUSSION: These findings expand the genetic architecture of sCJD in non‐European populations and support lipid metabolism and ER protein quality control as candidate pathways in prion disease susceptibility.
- Open Access
- 24 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9524
Inhibition of miR-148a-3p Ameliorates Prion Accumulation by Restoring ATP6AP2-Mediated Lysosomal Acidification
Prion diseases (PrDs) are fatal neurodegenerative disorders characterized by the accumulation of misfolded prion protein (PrPSc) and progressive impairment of protein quality-control systems. Lysosomal dysfunction and defective autophagic flux contribute to PrPSc accumulation, but the upstream regulatory mechanisms remain incompletely defined. In this study, we investigated the regulatory role of miR-148a-3p during prion infection. We found that miR-148a-3p expression is markedly increased in ME7- and 139A-infected mouse brains and prion-infected SMB-S15 cells. Dual-luciferase assays confirmed that miR-148a-3p directly targets the PRNP 3′UTR, negatively regulating cellular PrP expression. In prion-infected cells, inhibition of miR-148a-3p reduced proteinase K (PK)-resistant PrP (PrPres), delayed RT-QuIC conversion, and decreased PMCA-amplified PrPres. Through bioinformatic prediction and experimental validation, we identified ATP6AP2, a V-ATPase-associated regulator of lysosomal acidification, as a high-confidence target of miR-148a-3p. ATP6AP2 expression was significantly decreased in sCJD transcriptomic data, scrapie-infected mouse brains, and prion-infected cells. Importantly, inhibition of miR-148a-3p restored ATP6AP2 expression, which improved lysosomal acidification and alleviated impaired autophagic flux. Furthermore, overexpression of ATP6AP2 directly reduced PrPSc accumulation in SMB-S15 cells and diminished prion seeding capacities in RT-QuIC and PMCA assays. These findings identify miR-148a-3p as an upstream regulator of ATP6AP2-dependent lysosomal dysfunction in prion infection. Inhibition of miR-148a-3p may restore lysosomal clearance capacity and reduce PrPSc accumulation, suggesting a potential regulatory strategy for PrDs.
- 24 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9524
Open AccessInhibition of miR-148a-3p Ameliorates Prion Accumulation by Restoring ATP6AP2-Mediated Lysosomal Acidification
Prion diseases (PrDs) are fatal neurodegenerative disorders characterized by the accumulation of misfolded prion protein (PrPSc) and progressive impairment of protein quality-control systems. Lysosomal dysfunction and defective autophagic flux contribute to PrPSc accumulation, but the upstream regulatory mechanisms remain incompletely defined. In this study, we investigated the regulatory role of miR-148a-3p during prion infection. We found that miR-148a-3p expression is markedly increased in ME7- and 139A-infected mouse brains and prion-infected SMB-S15 cells. Dual-luciferase assays confirmed that miR-148a-3p directly targets the PRNP 3′UTR, negatively regulating cellular PrP expression. In prion-infected cells, inhibition of miR-148a-3p reduced proteinase K (PK)-resistant PrP (PrPres), delayed RT-QuIC conversion, and decreased PMCA-amplified PrPres. Through bioinformatic prediction and experimental validation, we identified ATP6AP2, a V-ATPase-associated regulator of lysosomal acidification, as a high-confidence target of miR-148a-3p. ATP6AP2 expression was significantly decreased in sCJD transcriptomic data, scrapie-infected mouse brains, and prion-infected cells. Importantly, inhibition of miR-148a-3p restored ATP6AP2 expression, which improved lysosomal acidification and alleviated impaired autophagic flux. Furthermore, overexpression of ATP6AP2 directly reduced PrPSc accumulation in SMB-S15 cells and diminished prion seeding capacities in RT-QuIC and PMCA assays. These findings identify miR-148a-3p as an upstream regulator of ATP6AP2-dependent lysosomal dysfunction in prion infection. Inhibition of miR-148a-3p may restore lysosomal clearance capacity and reduce PrPSc accumulation, suggesting a potential regulatory strategy for PrDs.
- Open Access
- 19 August 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Estimating the Penetrance of PRNP Mutations in Chinese Prion Disease Patients based on the Genome Databases
Genetic prion diseases (gPrDs) are directly caused by mutations in the prion protein gene (PRNP). Although several mutations have been strongly linked to disease manifestation, the penetrance of many variants remains uncertain. This study aimed to clarify the penetrance of PRNP variants by analyzing data from the Chinese surveillance system and comparing them to large genome databases representing East Asian and global genetic backgrounds. Our analysis included 301 gPrD cases with PRNP point mutations alongside 96,462 individuals of East Asian genetic descent and 784,714 from a global cohort. Notably, the D178N, E200K, and P102L mutations exhibited high penetrance irrespective of genetic background, underscoring their pathogenic potential. T188K, the most frequent variant in Chinese gPrD cases, also showed high penetrance across all cohorts despite its regional specificity. Conversely, estimates of E196A penetrance were low, particularly in the Chinese and East Asian cohorts. Variants such as S97N and R148H showed extremely low penetrance across all cohorts, while V180I and V210I displayed distinct regional and ethnic variations in both prevalence and penetrance. However, the penetrance of rare mutations could not be reliably estimated due to insufficient case numbers. These insights highlight the complex interplay between genetic variation and disease risk, necessitating further investigation into the genetic epidemiology of gPrD.
- 19 August 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Open AccessEstimating the Penetrance of PRNP Mutations in Chinese Prion Disease Patients based on the Genome Databases
Genetic prion diseases (gPrDs) are directly caused by mutations in the prion protein gene (PRNP). Although several mutations have been strongly linked to disease manifestation, the penetrance of many variants remains uncertain. This study aimed to clarify the penetrance of PRNP variants by analyzing data from the Chinese surveillance system and comparing them to large genome databases representing East Asian and global genetic backgrounds. Our analysis included 301 gPrD cases with PRNP point mutations alongside 96,462 individuals of East Asian genetic descent and 784,714 from a global cohort. Notably, the D178N, E200K, and P102L mutations exhibited high penetrance irrespective of genetic background, underscoring their pathogenic potential. T188K, the most frequent variant in Chinese gPrD cases, also showed high penetrance across all cohorts despite its regional specificity. Conversely, estimates of E196A penetrance were low, particularly in the Chinese and East Asian cohorts. Variants such as S97N and R148H showed extremely low penetrance across all cohorts, while V180I and V210I displayed distinct regional and ethnic variations in both prevalence and penetrance. However, the penetrance of rare mutations could not be reliably estimated due to insufficient case numbers. These insights highlight the complex interplay between genetic variation and disease risk, necessitating further investigation into the genetic epidemiology of gPrD.
- Open Access
- 2 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (5) , 2344
The Anti-Apoptotic Activity of β-Synuclein Mediated via Akt Signaling Is Severely Lost During Prion Infection
Prion diseases are fatal neurodegenerative disorders characterized by profound neuronal damage. Despite evidence supporting a neuroprotective role for β-synuclein (β-syn) in neurodegeneration, its potential functions and mechanisms in prion disease have not been elucidated. To investigate the role of β-syn, we systematically analyzed its alterations in the central nervous system of several prion-infected rodent models and cell models. A series of biochemical, cellular, and immunofluorescence assays were conducted to explore the relationship between β-syn and protein kinase B (Akt) signaling and between β-syn and prion protein (PrP), and its neuroprotective role in prion disease. Student’s t-test was used for statistics. At the terminal stage of prion disease, β-syn and Akt exhibited a parallel and remarkable decrease in rodent brains, contrasting with the slight but significant increase observed at early to middle stages. Dual-stained immunofluorescence assays confirmed that β-syn is localized within NeuN-positive neurons. Further structural and functional analyses revealed a high-affinity molecular interaction between β-syn and Akt, with the N-terminal region of β-syn being essential for binding to Akt1. In a cell model of PrP aggregation, β-syn overexpression suppressed cytochrome c-induced apoptosis, which was demonstrated by decreased levels of cleaved caspase-3. Notably, this anti-apoptotic effect was partially abolished upon Akt knockdown, indicating a dependence on Akt signaling. Moreover, colocalization of β-syn and PrP was observed in rodent brains. Consistently, in cellular models of prion infection and PrP aggregation, β-syn overexpression not only reduced PrP levels but also ameliorated its aberrant histological distribution. Our findings demonstrate that the anti-apoptotic activity of β-syn, mediated via Akt signaling, is severely lost during prion infection, thereby suggesting a mechanism of intrinsic neuronal vulnerability and revealing a novel therapeutic strategy.
- 2 March 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (5) , 2344
Open AccessThe Anti-Apoptotic Activity of β-Synuclein Mediated via Akt Signaling Is Severely Lost During Prion Infection
Prion diseases are fatal neurodegenerative disorders characterized by profound neuronal damage. Despite evidence supporting a neuroprotective role for β-synuclein (β-syn) in neurodegeneration, its potential functions and mechanisms in prion disease have not been elucidated. To investigate the role of β-syn, we systematically analyzed its alterations in the central nervous system of several prion-infected rodent models and cell models. A series of biochemical, cellular, and immunofluorescence assays were conducted to explore the relationship between β-syn and protein kinase B (Akt) signaling and between β-syn and prion protein (PrP), and its neuroprotective role in prion disease. Student’s t-test was used for statistics. At the terminal stage of prion disease, β-syn and Akt exhibited a parallel and remarkable decrease in rodent brains, contrasting with the slight but significant increase observed at early to middle stages. Dual-stained immunofluorescence assays confirmed that β-syn is localized within NeuN-positive neurons. Further structural and functional analyses revealed a high-affinity molecular interaction between β-syn and Akt, with the N-terminal region of β-syn being essential for binding to Akt1. In a cell model of PrP aggregation, β-syn overexpression suppressed cytochrome c-induced apoptosis, which was demonstrated by decreased levels of cleaved caspase-3. Notably, this anti-apoptotic effect was partially abolished upon Akt knockdown, indicating a dependence on Akt signaling. Moreover, colocalization of β-syn and PrP was observed in rodent brains. Consistently, in cellular models of prion infection and PrP aggregation, β-syn overexpression not only reduced PrP levels but also ameliorated its aberrant histological distribution. Our findings demonstrate that the anti-apoptotic activity of β-syn, mediated via Akt signaling, is severely lost during prion infection, thereby suggesting a mechanism of intrinsic neuronal vulnerability and revealing a novel therapeutic strategy.
- Open Access
- 9 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1678
High Proportions of GAP43 Positivity in the Cerebrospinal Fluids of Patients with Sporadic and Certain Types of Genetic Creutzfeldt-Jakob Diseases by Western Blot Analysis
Growth-associated protein-43 (GAP43) is a neuronal protein essential for synaptic function and plasticity, and its reduction has been observed in brains of prion diseases (PrDs) and rodent models. However, its status in the cerebrospinal fluid (CSF) of patients with PrDs remains unclear. CSF samples from 140 PrD cases, including 48 sCJD, 35 T188K-gCJD, 22 E200K-gCJD, 35 D178N-FFI, and 36 non-PrD controls, were analyzed for GAP43 by Western blot. The results were compared with 14-3-3 and calmodulin (CaM) detected by WB, and associated with clinical features. GAP43 positivity was significantly higher in sCJD (70.83%), T188K-gCJD (65.71%), and E200K-gCJD (72.73%) than in non-PrD controls (27.78%). The sensitivity and specificity of GAP43 (around 70–75%) were comparable to 14-3-3 and CaM, though inferior to RT-QuIC and total tau reported elsewhere. CSF GAP43 positivity correlated with sCJD-associated MRI changes, periodic sharp-wave complexes (PSWC) on EEG, and with 14-3-3 and CaM positivity. Our data here indicate the feasibility of usage of GAP43 by Western blot analysis as a diagnostic, at least as a screening, biomarker for sCJD and certain types of gPrDs.
- 9 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1678
Open AccessHigh Proportions of GAP43 Positivity in the Cerebrospinal Fluids of Patients with Sporadic and Certain Types of Genetic Creutzfeldt-Jakob Diseases by Western Blot Analysis
Growth-associated protein-43 (GAP43) is a neuronal protein essential for synaptic function and plasticity, and its reduction has been observed in brains of prion diseases (PrDs) and rodent models. However, its status in the cerebrospinal fluid (CSF) of patients with PrDs remains unclear. CSF samples from 140 PrD cases, including 48 sCJD, 35 T188K-gCJD, 22 E200K-gCJD, 35 D178N-FFI, and 36 non-PrD controls, were analyzed for GAP43 by Western blot. The results were compared with 14-3-3 and calmodulin (CaM) detected by WB, and associated with clinical features. GAP43 positivity was significantly higher in sCJD (70.83%), T188K-gCJD (65.71%), and E200K-gCJD (72.73%) than in non-PrD controls (27.78%). The sensitivity and specificity of GAP43 (around 70–75%) were comparable to 14-3-3 and CaM, though inferior to RT-QuIC and total tau reported elsewhere. CSF GAP43 positivity correlated with sCJD-associated MRI changes, periodic sharp-wave complexes (PSWC) on EEG, and with 14-3-3 and CaM positivity. Our data here indicate the feasibility of usage of GAP43 by Western blot analysis as a diagnostic, at least as a screening, biomarker for sCJD and certain types of gPrDs.